Boundless Bio Inc [NASDAQ: BOLD] slipped around -0.14 points on Wednesday, while shares priced at $2.52 at the close of the session, down -5.26%.
Compared to the average trading volume of 66.66K shares, BOLD reached a trading volume of 131338 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
What do top market gurus say about Boundless Bio Inc [BOLD]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BOLD shares is $18.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BOLD stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Piper Sandler have made an estimate for Boundless Bio Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on April 22, 2024. While these analysts kept the previous recommendation, Leerink Partners raised their target price to Outperform. The new note on the price target was released on April 22, 2024, representing the official price target for Boundless Bio Inc stock. Previously, the target price had yet another raise to $24, while Guggenheim analysts kept a Buy rating on BOLD stock.
The Average True Range (ATR) for Boundless Bio Inc is set at 0.25 The Price to Book ratio for the last quarter was 0.34, with the Price to Cash per share for the same quarter was set at 7.49.
How has BOLD stock performed recently?
Boundless Bio Inc [BOLD] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.01. With this latest performance, BOLD shares dropped by -19.49% in over the last four-week period, additionally sinking by -70.53% over the last 6 months.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BOLD stock in for the last two-week period is set at 37.88, with the RSI for the last a single of trading hit 35.72, and the three-weeks RSI is set at 39.64 for Boundless Bio Inc [BOLD]. The present Moving Average for the last 50 days of trading for this stock 3.13, while it was recorded at 2.53 for the last single week of trading.
Boundless Bio Inc [BOLD]: Deeper insight into the fundamentals
Boundless Bio Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 17.03 and a Current Ratio set at 17.03.
Insider trade positions for Boundless Bio Inc [BOLD]
There are presently around $76.02%, or 85.84%% of BOLD stock, in the hands of institutional investors.
